Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biofluid Biopsies & High-Value Diagnostics 2015

Biofluid Biopsies & High-Value Diagnostics 2015

Date: Monday, 16 November 2015 - Tuesday, 17 November 2015
Location: Boston, USA


Keynote Speakers

Oscar Puig

Oscar Puig
Biomarker Leader, Hoffmann La Roche

Raghu Kalluri

Raghu Kalluri
Professor & Chairman, Department of Cancer Biology; Olla S. Stribling Distinguished Chair for Cancer Research, MD Anderson Cancer Center

David Wong

David Wong
Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles

Nicholas Dracopoli

Nicholas Dracopoli
Vice President/Head, Johnson & Johnson

Ellen Beasley

Ellen Beasley
Senior Vice President, Genomic Health Inc

Frank Slack

Frank Slack
Director, Institute for RNA Medicine, Beth Israel Deaconess Medical Center Cancer Center/Harvard Medical School

Lawrence Rajendran

Lawrence Rajendran
Velux Stiftung Professor for Systems and Cell Biology of Neurodegeneration, University of Zurich

Maximilian Diehn

Maximilian Diehn
Assistant Professor, Stanford University School of Medicine

Kendall Van Keuren-Jensen

Kendall Van Keuren-Jensen
Associate Professor, Translational Genomics Research Institute

Hsian-Rong Tseng

Hsian-Rong Tseng
Professor, Crump Institute for Molecular Imaging, California NanoSystems Institute, University of California-Los Angeles

Dominique PV de Kleijn

Dominique PV de Kleijn
Professor Experimental Vascular Surgery, University Medical Center Utrecht, The Netherlands

Xandra Breakefield

Xandra Breakefield
Professor, Mass General Hospital (MGH)/Harvard Medical School

Walter Koch

Walter Koch
Vice President, Roche Molecular Systems

Ranjan Perera

Ranjan Perera
Associate Professor, Scientific Director Genomics and Bioinformatics, Sanford Burnham Medical Research Institute

Shana Kelley

Shana Kelley
Professor, University Of Toronto

Chamindie Punyadeera

Chamindie Punyadeera
Associate Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology

Minetta Liu

Minetta Liu
Associate Professor and Chair, Oncology Research, Mayo Clinic

Lynn Sorbara

Lynn Sorbara
Program Director, National Cancer Institute

Overview

The 2nd Annual Biofluid Biopsies and High Value Diagnostics 2015 Conference brings together academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as other disease classes.

The Biofluid Biopsies Conference Track focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.  There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

The High-Value Diagnostics Conference Track explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for patient monitoring and precision/targeted medicine.

We also explore the front-end sample preparation challenges and approaches for the deployment of various biofluid classes (plasma, serum, urine, cerebrospinal fluid, ovarian follicular fluid, and saliva) into diagnostics development in both the conference tracks.

All conference delegates receive access to both concurrent, co-located conference tracks enabling maximal learning and maximizing networking opportunities.  The two tracks are intertwined and presentations from the two tracks en bloc provide a complete picture of the liquid biopsy space as it currently exists.

Present Your Research at this Conference in a Poster to a Worldwide Audience.  Poster Submission Deadline:  November 2, 2015.

Corporate Sponsors Media Sponsors Networking
U-Networks

Add to Calendar ▼2015-11-16 00:00:002015-11-17 00:00:00Europe/LondonBiofluid Biopsies and High-Value Diagnostics 2015Biofluid Biopsies and High-Value Diagnostics 2015 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com